Making an impact happens together.

We are conducting clinical studies at academic centers and physician practices. If you are interested in learning more or participating in these clinical trials, please click the links below.

Trial
ClinicalTrials.gov Identifier
Lyra Candidate
Indication
Enrollment Status
Trial

ENLIGHTEN 1: A Phase III, Randomized, Blinded, Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis (CRS) in Adults

ClinicalTrials.gov Identifier

NCT05219968

Lyra Candidate

LYR-210

Indication

Adult patients with chronic rhinosinusitis

Enrollment Status

Fully enrolled

Trial

ENLIGHTEN 2: A Phase III, Randomized, Blinded, Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults

ClinicalTrials.gov Identifier

NCT05295459

Lyra Candidate

LYR-210

Indication

Adult patients with chronic rhinosinusitis

Enrollment Status

Enrolling

Trial

BEACON: A Phase II, Patient-blinded, Two-part, Randomized, Parallel-group Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of LYR-220 in Chronic Rhinosinusitis (CRS) Patients Who Have Had a Prior Ethmoidectomy

ClinicalTrials.gov Identifier

NCT05035654

Lyra Candidate

LYR-220

Indication

Adult patients with chronic rhinosinusitis who have had a prior sinus surgery

Enrollment Status

Fully enrolled

© 2024 Lyra Therapeutics. All rights reserved.
Back to Top